Online citations, reference lists, and bibliographies.
← Back to Search

Consensus Report: Pretreatment Minimal Staging And Treatment Of Potentially Resectable Malignant Pleural Mesothelioma.

J. Van Meerbeeck, M. Boyer
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
he panel decided to discuss successively the issues f staging classification, pretreatment assessment nd treatment of potentially resectable malignant leural mesothelioma (MPM). Whenever possible a onsensus was agreed and areas of further research ere identified based on issues on which no agreeent could be obtained. Recommendations were ormulated based on the areas of consensus and disgreement.
This paper references
10.2214/AJR.166.2.8553940
The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
E. Patz (1996)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/S0169-5002(03)90438-7
E-31. The IASLC staging revision project
P. Goldstraw (2003)
10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging
C. Boutin (1993)
10.1016/s0147-0272(88)80005-9
Asbestos-related malignancy.
J. Talcott (1988)
10.1097/00000658-199609000-00005
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.
D. Sugarbaker (1996)
10.1097/00130404-200311000-00008
Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest
A. Ahamad (2003)
10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
C. Boutin (1993)
10.1200/JCO.2004.10.071
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2004)
10.1378/CHEST.116.SUPPL_3.450S
Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.
S. Grondin (1999)
10.1016/S1095-0397(00)00077-7
11. Evaluation of Patients with Known Mesothelioma with 18F-Fluorodeoxyglucose and PET. Comparison with Computed Tomography.
Zubeldia (2000)
10.1016/S0003-4975(99)01038-3
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
10.1016/0169-5002(94)00404-B
Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
L. Tammilehto (1995)
10.1148/RG.242035075
Patterns of lymphadenopathy in thoracic malignancies.
A. Sharma (2004)
10.2214/AJR.172.4.10587144
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
10.1016/S0022-5223(97)70397-0
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.
U. Pastorino (1997)
Thoracic surgery : surgical management of pleural diseases
J. Deslauriers (1990)
10.2214/AJR.159.5.1414807
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
E. Patz (1992)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)



This paper is referenced by
10.1586/era.09.2
Future developments in the management of malignant pleural mesothelioma
Paolo Andrea Zucali (2009)
10.1634/THEONCOLOGIST.12-7-850
Multidisciplinary treatment of malignant pleural mesothelioma.
G. Ceresoli (2007)
of Thoracic Surgeons for management of Malignant Pleural Mesothelioma
A. Scherpereel (2009)
10.1590/S0100-39842010000400010
Lista de recomendações do Exame PET/CT com 18F-FDG em Oncologia: consenso entre a Sociedade Brasileira de Cancerologia e a Sociedade Brasileira de Biologia, Medicina Nuclear e Imagem Molecular
J. S. Júnior (2010)
10.1590/S1806-37132008000100004
[Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital].
R. Terra (2008)
10.1016/S0761-8425(06)71784-3
3. Quel bilan pré-thérapeutique faut-il proposer à un patient porteur d’un mésothéliome pleural malin (MPM)?
J. Margery (2006)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1016/J.CCM.2006.01.004
Management of malignant pleural mesothelioma.
S. West (2006)
10.1016/S0761-8425(06)71785-5
4.1. Mésothéliome pleural malin: place de la chirurgie d’exérèse
R. Giudicelli (2006)
10.1016/S0761-8425(07)78148-2
Mésothéliome pleural : conséquences de la stadification sur la stratégie thérapeutique
L. Greillier (2007)
10.1053/j.semtcvs.2009.07.003
Making the case for molecular staging of malignant pleural mesothelioma.
R. Bueno (2009)
10.1245/s10434-006-9160-3
Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument
R. Cameron (2006)
10.3747/CO.V15I2.251
Malignant mesothelioma: Canadian perspective and research directions
C. Lee (2008)
10.1016/j.critrevonc.2010.04.004
Malignant pleural mesothelioma: the standard of care and challenges for future management.
J. Van Meerbeeck (2011)
Parameters Incorporating Quantitative FDG-PET Imaging with Clinical A Novel Prognostic Model for Malignant Mesothelioma
A. Nowak (2010)
10.3779/j.issn.1009-3419.2010.10.14
[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].
Arnaud Scherpereel (2010)
10.1002/9780470025079.CHAP49.PUB2
Pleura and Peritoneum
M. Sheaff (2007)
10.1016/J.HOC.2005.09.009
Prognostic factors for mesothelioma.
J. Steele (2005)
10.3816/CLC.2009.n.014
Malignant pleural mesothelioma: medical treatment update.
D. Vorobiof (2009)
10.1158/1078-0432.CCR-09-2313
A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
A. Nowak (2010)
10.4155/CLI.11.72
Treatment of malignant pleural mesothelioma: current status and future directions
P. Zucali (2011)
10.1158/1078-0432.CCR-07-5283
Transesophageal Endoscopic Ultrasound with Fine Needle Aspiration in the Preoperative Staging of Malignant Pleural Mesothelioma
K. Tournoy (2008)
10.1002/DC.20740
Endoscopic ultrasound‐guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma
S. Bean (2008)
Semantic Scholar Logo Some data provided by SemanticScholar